Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes.

Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes.

Item

http://www.wikidata.org/entity/Q34283092

Q34283092

about

Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes An inflammatory cascade leading to hyperresistinemia in humans Serum resistin is associated with C-reactive protein & LDL cholesterol in type 2 diabetes and coronary artery disease in a Saudi population.Pancreatic regulation of glucose homeostasis Haploinsufficiency of akt1 prolongs the lifespan of mice Diabetic cardiomyopathy: signaling defects and therapeutic approaches Efficacy of antioxidant treatment in reducing resistin serum levels: a randomized study The macrophage at the intersection of immunity and metabolism in obesity Serum resistin positively correlates with serum lipids, but not with insulin resistance, in first-degree relatives of type-2 diabetes patients: an observational study in China.Relationship between obesity, adipocytokines and inflammatory markers in type 2 diabetes: relevance for cardiovascular risk prevention Distinct vascular and metabolic effects of different classes of anti-hypertensive drugs.The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3 Visfatin is regulated by rosiglitazone in type 2 diabetes mellitus and influenced by NFκB and JNK in human abdominal subcutaneous adipocytes.Maternal leptin, adiponectin, resistin, visfatin and tumor necrosis factor-alpha in normal and gestational diabetes Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.Protein-energy wasting and mortality in chronic kidney disease.Resistin gene variation is associated with systemic inflammation but not plasma adipokine levels, metabolic syndrome or coronary atherosclerosis in nondiabetic Caucasians.Serum adiponectin, resistin, and circulating soluble receptor for advanced glycation end products in colectomy patients.Association of circulating resistin with metabolic risk factors in Indian females having metabolic syndrome.The current biology of resistin.Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum Resistin: functional roles and therapeutic considerations for cardiovascular disease.Role of impaired insulin secretion and insulin resistance in the pathogenesis of type 2 diabetes mellitus.Diabetic cardiomyopathy: is resistin a culprit?Fat as an endocrine organ: influence of exercise.Genome-wide association analysis identifies TYW3/CRYZ and NDST4 loci associated with circulating resistin levels.Visfatin in human pregnancy: maternal gestational diabetes vis-à-vis neonatal birthweight.Prediagnostic circulating adipokine concentrations and risk of renal cell carcinoma in male smokers.Correlates of resistin in children with chronic kidney disease: the chronic kidney disease in children cohort.Selective PPAR modulators, dual and pan PPAR agonists: multimodal drugs for the treatment of type 2 diabetes and atherosclerosis.Human resistin inhibits myogenic differentiation and induces insulin resistance in myocytes.High insulin and leptin increase resistin and inflammatory cytokine production from human mononuclear cells.Maternal serum adiponectin multimers in gestational diabetes.Resistin - the link between adipose tissue dysfunction and insulin resistance in patients with obstructive sleep apnea.Role of resistin in cardiac contractility and hypertrophy.Clinical implications of adipocytokines and newly emerging metabolic factors with relation to insulin resistance and cardiovascular health.A QTL on 12q influencing an inflammation marker and obesity in white women: the NHLBI Family Heart Study.Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients.Resistin in rodents and humans.Adipokines: novel players in resistant hypertension.

P2860

Q21144473-69598167-1BDB-4AF7-A0C4-6D8F7DD3F513 Q24796813-670B736B-2F98-4D2A-9238-9E646258B6A8 Q24810956-8F7F6516-C4D5-463E-B4A6-D1500C8958C5 Q26766485-8AA6A30D-60F5-4DF2-9AAA-F829B47A886F Q28296350-2D35F725-22A2-4BA5-9BD5-C6A3887BCC78 Q28395852-B9BFBDE3-9914-4B19-9E54-C28565B0D41E Q28469198-5AC92D57-A6A2-4A9F-8E0E-FF0F2A1393EB Q30408713-9E1B017E-6DD5-4A71-9A6E-ECC092F7E5EB Q33606147-C5910D52-3A79-4432-A170-1B5665E31E74 Q33627732-C051170C-FC10-4AE0-9C0D-115B3B3B2907 Q33821236-9260BB2A-894E-40BC-9FDA-BDD89A88F7E2 Q33910196-2B09F619-C401-4BF6-9658-CA487B7A5FE9 Q33939122-13088265-8A45-4248-81A3-C5937FF4D4F0 Q34246872-53CF7CD6-E53B-4E24-BF0F-6FD301F9ED99 Q34779049-3865B16F-EC5A-42CB-8AAB-AAF02DA5CE63 Q35024794-1AA36B58-A008-42AB-8F13-37FB77932808 Q35025714-C2A4DFDC-E37D-41F7-90BF-9224297AF045 Q35201986-5349FBE6-E343-404C-BC3C-8ED39C41A759 Q35245193-2BCDD4E0-7445-4F14-9688-CB2863C134A1 Q35721044-129DBAD9-654D-4CFB-BAFF-A21EA717372B Q35760141-60BB171A-951C-4049-A8C7-D8B20846768F Q35859749-BAF1D1EA-00FB-4353-93BC-7A17C7DFBC60 Q36131766-1AD23F1B-522F-4DD9-9636-2792CE6524B9 Q36174452-9E7BED82-8A1C-4A6D-A4FD-00C9FE7C5723 Q36195348-59C60882-3F12-40FF-9387-501D04CFC239 Q36317713-5E57308A-5121-4840-98DF-91D2AAF096DB Q36419240-797B60F1-65E0-4058-B137-DDE98D2B6EF8 Q36499792-0CD6D029-F79E-41FE-9B9F-1990A855E57E Q36557932-74CA4102-BFDD-4824-9CB7-5BFC67ECF038 Q36580568-C8619B22-B527-4A01-90F3-2C7ACF0BC6E5 Q36663436-A76841D7-7570-4E2C-9573-AA700B06A27F Q36665152-E6B567E0-1ECC-4B4E-9E6C-002C742C66D4 Q36670594-14C7B553-03DB-4596-872C-21A16AF2E0F7 Q36686189-A8F481BE-2C3B-4C46-8B49-DFBFE9B190AB Q37034769-AD92F2D0-48BC-4E91-B27C-079C8B8DFE24 Q37108770-0459DEEC-98EC-4F49-9EE9-5096BA4DCCAC Q37129857-806E09C9-121D-4076-870B-7207D0778CCE Q37279905-85E39E75-2475-4C46-AE00-5E73414C0E23 Q37435682-97AEB096-C3A9-460D-866A-0BB9475D5448 Q38245895-43F20BE4-BCCD-41F2-95AF-63C11E697083

P2860

Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes.

Item

http://www.wikidata.org/entity/Q34283092

description

2003 nî lūn-bûn

@nan

2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu